Skip to main content
. 2015 Nov 16;6(1):e83–e90. doi: 10.1055/s-0035-1567857

Table 4. Neonatal characteristics.

USE (N = 71) Control (N = 74) p RR (95% CI)
Female 35 (47%) 40 (53%) 0.62 0.91 (0.63–1.31)
Birth weight 3,225 + 419 3,240 + 465 0.82
SGA (Alexander: BW< 10%) 9 (12%) 11 (15%) 0.81 0.91 (0.46–1.45)
 SGA detected antepartuma 6 (67%) 1 (9%) 0.03 1.87 (0.97–2.15)
LGA (Alexander; BW > 90%) 5 (7%) 3 (4%) 0.48 1.29 (0.52–1.92)
 LGA detected antepartumb 4 (80%) 0 (0%) 0.06 2.07 (1.69–2.55)
Macrosomia (≥ 4,000 g) 2 (3%) 4 (5%) 0.68 0.67 (0.12–1.57)
 Macrosomia detected antepartum 0 0
AS < 4 at 1 min 2 (3%) 3 (4%) 1.00 0.81 (0.14–1.73)
AS < 4 at 5 min 2 (3%) 0 0.41 1.66 (0.85–3.15)
UApH
 < 7.10 0 4 (5%) 0.50 0.22 (0.01–3.02)
 < 7.00 0 2 (3%) 0.62 0.03–4.83
NICU admission 2 (3%) 2 (3%) 1.00 1.02 (0.18–1.89)
Composite neonatal morbidityc 6 (8%) 2 (3%) 0.16 1.58 (0.73–2.06)

Abbreviations: USE, ultrasonographic examination; RR, relative risk; CI, confidence intervals; SGA, small for gestational age; LGA, large for gestational age; NICU, neonatal intensive care unit.

a

Fetus diagnosed as FGR (abdominal circumference or estimated fetal weight <10%).

b

Fetus with abdominal circumference or estimated fetal weight >90% for gestational age.

c

Composite neonatal morbidity consisted of any of the following: respiratory distress syndrome, transient tachypnea of the newborn, hyperbilirubinemia, seizures, hypoglycemia, proven sepsis, intraventricular hemorrhage III/IV, necrotizing enterocolitis.